Trial intelligence / Profile preview

Restasis in Low Humidity for Dry Eye

NCT02199964Phase 4Terminated

Sponsor
Baylor College of Medicine
Start
Mar 2014
Primary completion
Dec 2015
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of cyclosporine in dry eye syndrome (DED), sponsored by Baylor College of Medicine. Primary endpoint: Corneal Fluorescein Staining at 6 weeks. Started Mar 2014; status: terminated.

02

Drugs

cyclosporine
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT02199964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02199964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call